Code Blue Receives Kirkus Star

Posted on | March 13, 2019 | Comments Off on Code Blue Receives Kirkus Star

KIRKUS REVIEW

“A doctor and medical historian relies on his experience inside the medical establishment to offer a searing and persuasive exposé of the American health care system.

Magee, who is on the faculty of Presidents College at the University of Hartford, has worked as a doctor, a university medical school administrator, a hospital executive, and head of global medical affairs for Pfizer. About that last position, the author writes, “until I turned away in a kind of revulsion at the manipulation and well-financed maneuvering, I was right there, helping give moral cover and scientific legitimacy to the world’s largest drugmaker, which also happens to be an industry leader in penalty fees paid to the government for regulatory infractions.” Clearly, Magee understands that he has been complicit as an insider, and he issues mea culpas throughout the book. As part of his penance, he blows the whistle on guilty individuals involved with pharmaceutical companies, hospitals, health insurance corporations, the American Medical Association, medical schools, and all levels of U.S. government. Referring to this “network of mutually beneficial relationships” as the Medical Industrial Complex, he convincingly rails against an industry that consistently produces “outcomes that are, in general, truly dismal.” The inferiority of U.S. health care compared to dozens of other nations has been well-documented for several decades, and the author effectively builds on that documentation. He demonstrates how leaders of other nations have consciously decided that quality health care is a basic right for all citizens, in large part because a healthy citizenry is essential to economic well-being. However, decades ago, American leaders decided that quality health care was not a basic right of citizenship; instead, they chose to rely on market capitalism as the health care model, with disastrous results. Magee suggests multiple sensible reforms in the realms of medical education, clinical research, publication of medical trials, marketing by pharmaceutical companies, and politically driven interactions within the MIC.

Readers will hope that Magee’s knowledgeable, urgent indictment, following so many others in recent years, will lead to meaningful reforms.”